EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 33 (2026) Parasite, 33 (2026) 3 References
Open Access
Issue
Parasite
Volume 33, 2026
Article Number 3
Number of page(s) 8
DOI https://doi.org/10.1051/parasite/2026003
Published online 23 January 2026
  1. Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Pretell EJ, Castillo Y, Perez E, Dorny P, Gilman RH, O'Neal SE, Gonzalez AE, Garcia HH, Cysticercosis Working Group in Peru (CWGP). 2022. Improved diagnosis of viable parenchymal neurocysticercosis by combining antibody banding patterns on enzyme-linked immunoelectrotransfer blot (EITB) with antigen enzyme-linked immunosorbent assay (ELISA). Journal of Clinical Microbiology, 60, e0155021. [Google Scholar]
  2. Arroyo G, Rodriguez S, Lescano AG, Alroy KA, Bustos JA, Santivañez S, Gonzales I, Saavedra H, Pretell EJ, Gonzalez AE, Gilman RH, Tsang VCW, Garcia HH, Cysticercosis Working Group in Peru. 2018. Antibody banding patterns of the enzyme-linked immunoelectrotransfer blot and brain imaging findings in patients with neurocysticercosis. Clinical Infectious Diseases, 66, 282–288. [Google Scholar]
  3. Carpio A, Fleury A, Romo ML, Abraham R, Fandiño J, Durán JC, Cárdenas G, Moncayo J, Leite Rodrigues C, San-Juan D, Serrano-Dueñas M, Takayanagui O, Sander JW. 2016. New diagnostic criteria for neurocysticercosis: Reliability and validity. Annals of Neurology, 80, 434–442. [Google Scholar]
  4. Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM. 2016. STARD2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open, 14, e012799. [CrossRef] [PubMed] [Google Scholar]
  5. Donadeu M, Fahrion AS, Olliaro PL, Abela-Ridder B. 2017. Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. PLoS Neglected Tropical Diseases, 11, e0005875. [Google Scholar]
  6. Galen RS. 1980. Predictive value and efficiency of laboratory testing. Pediatric Clinics of North America, 27, 861–869. [CrossRef] [PubMed] [Google Scholar]
  7. Garcia HH, Gonzalez AE, Gilman RH. 2020. Taenia solium cysticercosis and its impact in neurological disease. Clinical Microbiology Reviews, 33, e00085-19. [Google Scholar]
  8. Garcia HH, Nash TE, Del Brutto OH. 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurology, 13, 1202–1215. [Google Scholar]
  9. Hernández M, Astudillo OG, Diego G, de-la-Rosa-Arana JL, Meza-Lucas A, García-Rodea R, Romo ML, Toledo A, Parkhouse RM, Garate T, Sciutto E, Fleury A. 2019. Immunodiagnosis of human neurocysticercosis: comparative performance of serum diagnostic tests in Mexico. Parasitology Research, 118, 2891–2899. [Google Scholar]
  10. Intapan PM, Khotsri P, Kanpittaya J, Chotmongkol V, Maleewong W, Morakote N. 2008. Evaluation of IgG4 and total IgG antibodies against cysticerci and peptide antigens for the diagnosis of human neurocysticercosis by ELISA. Asian Pacific journal of Allergy and Immunology, 26, 237–244. [Google Scholar]
  11. Ito A, Plancarte A, Ma L, Kong Y, Flisser A, Cho SY, Liu YH, Kamhawi S, Lightowlers MW, Schantz PM. 1998. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. American Journal of Tropical Medicine and Hygiene, 59, 291–294. [Google Scholar]
  12. Kim SH, Bae YA, Yang Y, Hong ST, Kong Y. 2011. Paralogous proteins comprising the 150 kDa hydrophobic-ligand-binding-protein complex of the Taenia solium metacestode have evolved non-overlapped binding affinities toward fatty acid analogs. International Journal for Parasitology, 41, 1207–1215. [Google Scholar]
  13. Landis JR, Koch GG. 1977. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics, 33, 363–374. [CrossRef] [PubMed] [Google Scholar]
  14. Lee EG, Kim SH, Bae YA, Chung JY, Suh M, Na BK, Kim TS, Kang I, Ma L, Kong Y. 2007. A hydrophobic ligand-binding protein of the Taenia solium metacestode mediates uptake of the host lipid: implication for the maintenance of parasitic cellular homeostasis. Proteomics, 7, 4016–4030. [Google Scholar]
  15. Mubanga C, Mwape KE, Phiri IK, Trevisan C, Zulu G, Chabala C, van Damme I, Schmidt V, Dorny P, Gabriël S. 2019. Progress on the development of rapid diagnostic tests for foodborne neglected zoonotic helminthiases: A systematic review. Acta Tropica, 194, 135–147. [Google Scholar]
  16. Mubanga C, Van Damme I, Trevisan C, Schmidt V, Phiri IK, Zulu G, Noh J, Handali S, Mambo R, Chembensofu M, Masuku M, Reynders D, Jansen F, Bottieau E, Magnussen P, Winkler AS, Dorny P, Mwape KE, Gabriël S. 2021. Evaluation of an antibody detecting point of care test for diagnosis of Taenia solium cysticercosis in a Zambian rural community: A prospective diagnostic accuracy study. Diagnostics, 11, 2121. [Google Scholar]
  17. Pujari A, Bhaskaran K, Modaboyina S, Das D, Saluja G, Samdani A, Singh P, Bajaj MS, Sharma N. 2022. Cysticercosis in ophthalmology. Survey of Ophthalmology, 67, 544–569. [Google Scholar]
  18. Sadaow L, Boonroumkaew P, Rodpai R, Janwan P, Sanpool O, Thanchomnang T, Morishima Y, Sato MO, Sako Y, Kobayashi K, Iwai M, Maleewong W, Yamasaki H, Intapan PM. 2023. Development and evaluation of an immunochromatography-based point- of-care test kit for a rapid diagnosis of human cysticercosis. Food and Waterborne Parasitology, 33, e00211. [Google Scholar]
  19. Saeed N, Ehsan A, Vasenwala SM. 2017. Disseminated cysticercosis incidentally diagnosed in a patient of fracture shaft of femur. BMJ Case Reports, 2017 bcr2016217451. [Google Scholar]
  20. Sako Y, Itoh S, Okamoto M, Nakaya K, Ito A. 2013. Simple and reliable preparation of immunodiagnostic antigens for Taenia solium cysticercosis. Parasitology, 140, 1589–1594. [Google Scholar]
  21. Sako Y, Nakao M, Nakaya K, Yamasaki H, Ito A. 2006. Recombinant antigens for serodiagnosis of cysticercosis and echinococcosis. Parasitology International, 55 Suppl, S69–S73. [CrossRef] [PubMed] [Google Scholar]
  22. Sato MO, Cavalcante TV, Sako Y, Nakao M, Yamasaki H, Yatsuda AP, Nakaya K, Ito A. 2006. Evidence and potential for transmission of human and swine Taenia solium cysticercosis in the Piracuruca region, Piauí, Brazil. American Journal of Tropical Medicine and Hygiene, 75, 933–935. [Google Scholar]
  23. Sato MO, Sako Y, Nakao M, Yamasaki H, Nakaya K, Ito A. 2006. Evaluation of purified Taenia solium glycoproteins and recombinant antigens in the serologic detection of human and swine cysticercosis. Journal of Infectious Diseases, 194, 1783–1790. [Google Scholar]
  24. Sato OM, Nunes CM, Sato M, Waikagul J. 2015. Taenia, in Food microbiology series, Biology of Foodborne Parasites, Xiao L, Ryan U, Feng Y, Editors. Boca Raton: CRC Press Taylor & Francis group. p. 463–480. [Google Scholar]
  25. Silva-Álvarez V, Folle AM, Ramos AL, Zamarreño F, Costabel MD, García-Zepeda E, Salinas G, Córsico B, Ferreira AM. 2015. Echinococcus granulosus antigen B: a hydrophobic ligand binding protein at the host-parasite interface. Prostaglandins, Leukotrienes & Essential Fatty Acids, 93, 17–23. [Google Scholar]
  26. Singh G, Burneo JG, Sander JW. 2013. From seizures to epilepsy and its substrates: neurocysticercosis. Epilepsia, 54, 783–792. [Google Scholar]
  27. Stelzle D, Abraham A, Kaminski M, Schmidt V, De Meijere R, Bustos JA, Garcia HH, Sahu PS, Bobić B, Cretu C, Chiodini P, Dermauw V, Devleesschauwer B, Dorny P, Fonseca A, Gabriël S, Morales MÁG, Laranjo-González M, Hoerauf A, Hunter E, Jambou R, Jurhar-Pavlova M, Reiter-Owona I, Sotiraki S, Trevisan C, Vilhena M,Walker NF, Zammarchi L, Winkler AS. 2023. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe. Journal of Travel Medicine, 30, taac102. [Google Scholar]
  28. Stelzle D, Makasi CE, Schmidt V, Van Damme I, Trevisan C, Ruether C, Fleury A, Noh J, Handali S, Dorny P, Magnussen P, Zulu G, Mwape KE, Bottieau E, Gabriël S, Ngowi BJ, Winkler AS, SOLID Collaborators. 2024. Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study. Lancet Infectious Diseases, 24, 98–106. [Google Scholar]
  29. Trevisan C, Damme IV, Ngowi B, Schmidt V, Stelzle D, Møller KS, Kabululu M, Makasi CE, Magnussen P, Bottieau E, Abatih E, Johansen MV, Ngowi H, Ndawi B, Mwape KE, Zulu G, Dorny P, Winkler AS, Gabriël S, On behalf of the solid consortium. 2021. Trial design of a prospective multicenter diagnostic accuracy study of a point-of-care test for the detection of Taenia solium taeniosis and neurocysticercosis in hospital-based settings in Tanzania. Diagnostics, 11, 1528. [Google Scholar]
  30. Tsang VC, Brand JA, Boyer AE. 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). Journal of Infectious Diseases, 159, 50–59. [Google Scholar]
  31. Van Damme I, Trevisan C, Kabululu M, Stelzle D, Makasi CE, Schmidt-Urbaneja V, Mwape KE, Mubanga C, Zulu G, Møller KS, Jansen F, Reynders D, Noh J, Handali S, Bottieau E, Winkler AS, Dorny P, Magnussen P, Gabriël S, Ngowi B. 2025. Evaluation of a rapid lateral flow assay for the detection of taeniosis and cysticercosis at district hospital level in Tanzania: A prospective multicentre diagnostic accuracy study. PLoS Neglected Tropical Diseases, 19, e0012310. [Google Scholar]
  32. Yamasaki H. 2013. Current status and perspectives of cysticercosis and taeniasis in Japan. Korean Journal of Parasitology, 51, 19–29. [Google Scholar]
  33. Yamasaki H, Araki K, Lim PK, Zasmy N, Mak JW, Taib R, Aoki T. 2000. Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. Journal of Clinical Microbiology, 38, 1409–1413. [Google Scholar]
  34. Yamasaki H, Sato MO, Sako Y, Nakao M, Nakaya K, Mamuti W, Craig PS, Margono SS, Ito A. 2003. Cysticercosis/taeniasis: recent advances in serological and molecular diagnosis. Southeast Asian Journal of Tropical Medicine and Public Health, 34 (Suppl 2), 98–102. [Google Scholar]
  35. World Health Organization. 2022. Taeniasis-cysticercosis. Available at https://www.who.int/en/news-room/fact-sheets/detail/taeniasis-cysticercosis/. Accessed date:13 April 2023. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.